5 Results for "

superparamagnetic iron oxide nanoparticles

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "superparamagnetic iron oxide nanoparticles" in MCE Product Catalog:

Cat. No.: HY-164071
CAS No.: 9044-05-7
Synonyms: CM-Dextran
Target:  

Drug Derivative

Research Areas:  

Others

Carboxymethyl Dextran (CM-Dextran) is a dextran derivative and a biocompatible coating for superparamagnetic iron oxide nanoparticles. When coated on the surface of superparamagnetic nanoparticles, Carboxymethyl Dextran forms stable particles across all pH values and NaCl concentrations. Carboxymethyl Dextran can be used to prepare materials for magnetic resonance molecular imaging .
loading...
    loading...
Cat. No.: HY-177205
Research Areas:  

Others

DSPE-PEG2000-CRPPR is a polyethylene glycol (PEG) conjugate composed of DSPE and Heart-homing peptide (CRPPR) (HY-P10641). DSPE-PEGs are modified with the CRPPR peptide to bind cysteine-rich protein 2 (CRIP2) as well as FITC-labeled superparamagnetic iron oxide nanoparticles .
loading...
    loading...
Cat. No.: HY-174906A
Research Areas:  

Others

Bis-PEG2000-COOH is a dicarboxyl-terminated polyethylene glycol and surface modification reagent with hydrophilic, biocompatible properties. Bis-PEG2000-COOH coats superparamagnetic iron oxide nanoparticles to prepare carriers for conjugating antigen p210 and adjuvant CpG oligodeoxynucleotides in nanovaccine formulation .
loading...
    loading...
Cat. No.: HY-184627
The core material of carboxylated dextran-modified iron oxide nanoparticles is iron oxide (Fe3O4), which possesses superparamagnetic properties, making it suitable for applications requiring magnetic field response. The surface is coated with carboxylated dextran, a modification that increases the nanoparticles' water solubility and biocompatibility, while also providing carboxyl functional groups, facilitating further chemical modification and biomolecular coupling.
loading...
    loading...
Cat. No.: HY-P11887
CAS No.: 1174559-81-9
VHPKQHR is a peptide-based delivery enhancer that binds to VCAM-1. VHPKQHR enables intracellular internalization of relevant nanomaterials and facilitates the targeted delivery of miRNA inhibitors to inflamed endothelial cells and endothelial cells activated by disturbed flow. When conjugated with magnetic mesoporous silica nanoparticles, VHPKQHR achieves targeted accumulation at atherosclerotic plaque sites. When displayed on the surface of polyelectrolyte complex micelles, VHPKQHR enhances the relevant effects of anti-miR-92a in Apoe -/- mice. When conjugated with ultrasmall superparamagnetic iron oxide nanoparticles, VHPKQHR forms a contrast agent for T1-weighted magnetic resonance imaging. VHPKQHR can be used in research related to atherosclerosis, stenosis and rheumatoid arthritis .
loading...
    loading...